web analytics
4.6 C
Munich
Sunday, April 18, 2021

ANY LAB TEST NOW; the Rise of EVIO Inc (OTCMKTS: EVIO)

EVIO Inc (OTCMKTS: EVIO) is making a powerful move up the charts in recent days after the Company formed a partnership with ANY LAB TEST NOW®, a leading provider of direct access lab testing with over 180 us locations. ANY LAB TEST NOW will now offer the EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content.

EVIO is moving higher every day; the stock was trading near $1 just a little over a year ago and has a large gap to fill from current levels. With OS at just 540 million and dollar volume creaping up over the US $1 million mark in recent daily trading volume penny stock speculators are accumulating.

EVIO Inc (OTCMKTS: EVIO) is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company’s EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. The Company’s EVIO Biosciences Division is dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system.

The Company’s wholly owned subsidiary is Evio labs; an analytical testing laboratory has been growing and has laboratories in Oregon, California, Massachusetts and Alberta, in addition the Company receives royalty revenues from licensed laboratories in Colorado and Florida. Evio labs provides cannabanoid potency profiling, complex terpene analysis, microbiological & pesticide screening and residual solvent analysis to service the projected 100,000 pounds of annual Oregon recreational sales. Currently Ellen Parkin serves as the laboratory director of  Evio Labs studying microbiology, fermentation science, and sensory science. After obtaining her MS in Fermentation Science from Oregon State University, she went on to work as Senior Lab Technician at Worthy Brewing Company where she built the lab up from a single microscope and pH meter to a fully functioning lab.

EVIO is led by a team of technology-focused professionals who came from Fortune-500 companies; the Company’s CEO William Waldrop is an executive who has led top management positions in a number of Company’s over the years. While at AirTouch Cellular, (now Verizon Wireless) he served as a Senior Manager contributing to the development and implementation of the National Retail Distribution Strategy and as a regional Sales Development Manager, he lead the formation of a 44-store, $100 million annual revenue distribution channel. He has over 12 years of experience in the Telecommunications industry where he has held several key management positions.

To Find out the inside Scoop on EVIO Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

EVIO

EVIO is fully reporting recently filing its Q3 results; for the 3 months ended June 30, 2020 EVO reported $603,192 in revenues from North American operations which includes company owned laboratories in Oregon, California, Massachusetts and Alberta, in addition to royalty revenues from licensed laboratories in Colorado and Florida was USD$1.05 million.

In a big move EVIO has established a partnership with ANY LAB TEST NOW®, a leading provider of direct access lab testing. ANY LAB TEST NOW® announced that it will now provide hemp oil and hemp derived CBD product testing for product manufacturers, retailers and consumers. ANY LAB TEST NOW® with over 180 walk-in locations across the US, will now offer the EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content. In addition, ANY LAB TEST NOW® customers can also test the actual products they use for Residual Solvents like butane and propane, a full list of cannabinoids, and, Vitamin E Acetate a substance linked to EVALI illnesses. ANY LAB TEST NOW® already has over 180 locations established in the US and posted $282 million in revenues last year.

“EVIO LABS is honored to be selected by ANY LAB TEST NOW® as their exclusive HEMP and CBD testing partner,” stated EVIO Labs CEO, William Waldrop “our mission is consumer safety and with so many new CBD products coming on line, having a partner with over 180 locations will provide CBD manufacturers, distributors and retailers local access to our testing platform.”

For more on EVIO Subscribe Right Now!

Currently running northbound off its triple zero lows EVIO is an exciting story developing in small caps; the company recently formed a partnership with ANY LAB TEST NOW®, a leading provider of direct access lab testing with over 180 us locations. ANY LAB TEST NOW will now offer the EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content. EVIO was trading near $1 just a little over a year ago and has a large gap to fill from current levels. With OS at just 540 million and dollar volume creeping up over the US $1 million mark in recent daily trading volume penny stock speculators are accumulating. We will be updating on EVIO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with EVIO.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in EVIO either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.